Tiotropium or salmeterol as add-on therapy to inhaled corticosteroids for patients with moderate symptomatic asthma: two replicate, double-blind, placebo-controlled, parallel-group, active-comparator, randomised trials

Post time 3 day(s) ago

Journal：Lancet Respir Med

Authors：Huib A M Kerstjens 1, Thomas B Casale 2, Eugene R Bleecker 3, Eli O Meltzer 4, Emilio Pizzichini 5, Olaf Schmidt 6, Michael Engel 7, Loek Bour 8, Cynthia B Verkleij 9, Petra Moroni-Zentgraf 7, Eric D Bateman 10

Published date：2015

DOI：10.1016/S2213-2600(15)00031-4

PDF link：
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(15)00031-4/abstract

Article link：10.1016/S2213-2600(15)00031-4

Post time 3 day(s) ago

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Elsevier] Tiotropium or salmeterol as add-on therapy to inhaled corticosteroids for patients with moderate symptomatic asthma: two replicate, double-blind, placebo-controlled, parallel-group, active-comparator, randomised trials

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Elsevier] Tiotropium or salmeterol as add-on therapy to inhaled corticosteroids for patients with moderate symptomatic asthma: two replicate, double-blind, placebo-controlled, parallel-group, active-comparator, randomised trials Copy

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Elsevier] Tiotropium or salmeterol as add-on therapy to inhaled corticosteroids for patients with moderate symptomatic asthma: two replicate, double-blind, placebo-controlled, parallel-group, active-comparator, randomised trials